Latest Benign Prostatic Hyperplasia (BPH) News
Review shows significant change in symptom scores, maximum urinary flow in sham surgery arm
Age, obesity promote methylation, suppression of 5-reductase 2
Increasing thickness was associated with increasing number of poor indicators for bladder outlet obstruction in men with enlarged prostates.
CAM associated with polypharmacy, vision impairment, and urologic comorbidities.
The malignancy is 36% less likely to develop, after adjusting for age and smoking, data show.
Symptom improvement was greater in patients receiving tamsulosin plus darifenacin compared with tamsulosin monotherapy.
In a study, only older age and greater total PSA density were independently associated with an increased risk of a PCa diagnosis.
Patients with BPH and mild-to-moderate LUTS can be managed without immediate prostatic surgery, study suggests.
Prostatic urethral lift is minimally invasive and, according to a new study, the procedure's beneficial effects are durable out to 3 years.
Neither drug decreased operative time, prostate volume, or weight of gland resected.
Overall, men with LUTS showed remarkably poor knowledge about their symptoms.
Ten years after the laser procedure, no reoperation was needed for 95% of patients treated for symptomatic benign prostatic hyperplasia.
Men who reported having severe lower urinary tract symptoms (LUTS) had a 64% increased risk of the malignancy compared with those who reported no LUTS.
Outcomes were significantly better in men with large prostates, however.
Depression is prevalent among men with benign prostatic hyperplasia (BPH).
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)